PCIA
MGNX icon

Prime Capital Investment Advisors’s MacroGenics MGNX Stock Holding History

Prime Capital Investment Advisors’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-500
Closed -$14K – 484
2020
Q2 		$14K Buy
+500
New +$8.69K ﹤0.01% 400

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Prime Capital Investment Advisors's MGNX Position: Q3 2020 in Review

Prime Capital Investment Advisors sold out of MacroGenics (MGNX) in Q3 2020, closing a stake of 500 shares — an estimated $14K sold.

Prime Capital Investment Advisors first reported a position in MGNX in Q2 2020 and held it in 1 quarter. The position peaked at $14K in Q2 2020. 139 funds tracked by Wall St. Rank hold MGNX as of Q3 2020.

  • Prime Capital Investment Advisors reported no remaining MacroGenics position as of Q3 2020 after selling out during the quarter.
  • Prime Capital Investment Advisors sold 500 MacroGenics shares in Q3 2020, an estimated $14K.
  • Prime Capital Investment Advisors first reported a position in MacroGenics in Q2 2020 and held it in 1 quarter.
  • Prime Capital Investment Advisors's MacroGenics position peaked at $14K in Q2 2020.
  • 139 funds tracked by Wall St. Rank held MacroGenics as of Q3 2020.

Based on Prime Capital Investment Advisors's 13F filing for Q3 2020, filed 6 Nov 2020.